Clinical Trials List
2020-08-21 - 2024-03-26
Phase III
Terminated7
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Yau-Lin Tseng Division of General Surgery
- Wu-Chou Su Division of Hematology & Oncology
- Seu-Chun Yang Division of General Internal Medicine
- Po-Lan Su Division of General Internal Medicine
- Xin-Min Liao Division of General Internal Medicine
- Chun-Hui Lee Division of Hematology & Oncology
- Yi-Ting Yen Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 方昱宏 Division of Hematology & Oncology
- 周晏立 Division of Thoracic Medicine
- 洪明賜 Division of Hematology & Oncology
- 何孟秦 Division of Hematology & Oncology
- 林玠模 Division of Infectious Disease
- 張哲嘉 Division of Thoracic Medicine
- 廖玉山 Division of Radiology
- 呂明憲 Division of Cardiovascular Surgery
- 林進國 Division of Infectious Disease
- 莊閔鈞 Division of Infectious Disease
- 李威諄 Division of Infectious Disease
- 林裕清 Division of Hematology & Oncology
- 黃舒儀 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 李易濰 Division of Radiology
- Chia-Cheng Tseng Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
- 王逸熙 Division of Thoracic Medicine
- 林理涵 Division of Radiology
- 黃國棟 Division of Thoracic Medicine
- 羅乾鳴 Division of Thoracic Surgery
- 呂宏益 Division of Thoracic Surgery
- 張晃智 Division of Thoracic Medicine
- 趙東瀛 Division of Thoracic Medicine
- 林孟志 Division of Thoracic Medicine
- Shau-Hsuan Li Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- 賴建豪 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Han-Shui Hsu Division of Thoracic Surgery
- 趙恒勝 Division of Thoracic Medicine
- Chi-Lu Chiang Division of Thoracic Medicine
- Yung-Hung Luo Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chih-Liang Wang Division of Hematology & Oncology
- 枋岳甫 Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- Yi-Chen Wu Division of Thoracic Surgery
- 柯皓文 Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- 吳青陽 Division of Thoracic Surgery
- Ping-Chih Hsu Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- Chao Yin-Kai Division of Thoracic Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- YEN-HAN TSENG Division of Thoracic Medicine
- Wei-Ciao Wu Division of Thoracic Surgery
- kang-Yun LEE Division of Thoracic Medicine
- YUN-KAI YEH Division of Thoracic Medicine
- Kuang-Tai Kuo Division of Thoracic Surgery
- Ching-Shan Luo Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
1500 participants
